Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56,066,823
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
16,043,055
-
Shares change
-
+1,987,107
-
Total reported value, excl. options
-
$78,561,424
-
Value change
-
+$9,453,621
-
Put/Call ratio
-
23%
-
Number of buys
-
53
-
Number of sells
-
-26
-
Price
-
$4.90
Significant Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) as of Q2 2024
108 filings reported holding ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q2 2024.
ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,043,055 shares
of 56,066,823 outstanding shares and own 29% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2,697,052 shares), Nantahala Capital Management, LLC (2,419,435 shares), VANGUARD GROUP INC (1,833,415 shares), Altium Capital Management LP (1,162,416 shares), Woodline Partners LP (1,147,583 shares), GEODE CAPITAL MANAGEMENT, LLC (914,264 shares), 683 Capital Management, LLC (800,000 shares), STATE STREET CORP (719,859 shares), Retirement Planning Co of New England, Inc. (458,300 shares), and Janney Montgomery Scott LLC (432,824 shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.